Patents by Inventor SHIH-TING KANG

SHIH-TING KANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911909
    Abstract: The present invention relates to a collision-free path generating method for a robot and an end effector quipped thereon to move. The method includes steps of configuring a virtual working environment, containing a plurality of virtual objects at least including the robot, the end effector and a target object consisting of a plurality of basic members and mapped from a working environment in a reality, in a robot simulator; selecting a level of detail and a pre-determined shape for a collider covering the plurality of virtual objects to determine boundaries for the plurality of objects; randomly sampling a combination of robot configurations; and based on the determine boundaries and the randomly sampled combination of robot configurations, performing a heuristic based pathfinding algorithm to compute a collision-free path for the robot and the end effector quipped thereon to move to the target object accordingly.
    Type: Grant
    Filed: August 17, 2021
    Date of Patent: February 27, 2024
    Assignee: SMART BUILDING TECH CO., LTD.
    Inventors: Shih-Chung Kang, Liang-Ting Tsai, Cheng-Hsuan Yang
  • Patent number: 11911911
    Abstract: The present invention relates to a near-site robotic construction system. The system includes a work station situated on a near-site position in a close proximity to a building foundation on which a building is under construction and providing shelter and workspace for at least one robot to work; and a computer-assisted cloud based near-site robotic construction platform installed on a cloud server system and configured to provide for a user to operate through a web browser, import and extract a building information modelling data, and plan a predetermined motion command set partly based on the extracted building information modelling data, wherein the at least one robot is configured to work in accordance with the predetermined motion command set to prefabricate a plurality of components for the building in the work station on the near-site position.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: February 27, 2024
    Assignee: SMART BUILDING TECH CO., LTD.
    Inventors: Shih-Chung Kang, Liang-Ting Tsai, Cheng-Hsuan Yang
  • Publication number: 20220180973
    Abstract: An early detection and prediction method of pan-cancer is provided, including the following steps. A microRNA expression profile database of cancer patient populations and healthy populations is established, and an early detection and prediction method of pan-cancer is developed based on the microRNA expression profile database. Next, a microRNA expression profile of a liquid biopsy sample of a subject is analyzed via the early detection and prediction method of pan-cancer, so as to determine whether the subject may already have cancer.
    Type: Application
    Filed: December 8, 2021
    Publication date: June 9, 2022
    Applicant: Quark Biosciences Taiwan, Inc.
    Inventors: Shih-Ting Kang, Wei-Ming Chen
  • Publication number: 20220076840
    Abstract: The disclosure provides a health risk assessment method including the following steps. A miRNA expression database of a healthy population is established. A miRNA expression in a plasma specimen of a subject is analyzed. After that, miRNA expression data of the subject is compared with the miRNA expression in the miRNA expression database of the healthy population, and the miRNA expression being too high or too low in the plasma specimen of the subject is found out to assess health risk of the subject.
    Type: Application
    Filed: December 24, 2019
    Publication date: March 10, 2022
    Applicant: Quark Biosciences Taiwan, Inc.
    Inventors: Wei-Ming Chen, Shih-Ting Kang
  • Publication number: 20210002698
    Abstract: The disclosure relates to methods for determining an endometrial status using a sample, for example, an endometrial biopsy, from a woman, comprising: (a) performing an assay on the endometrial sample from the woman to determine a microRNA (miRNA) expression profile of the endometrial sample, wherein the miRNA expression profile comprises expression levels of a plurality of miRNAs, for example, 167 miRNAs having the sequences of SEQ ID NOs:1-167, respectively; and (b) analyzing the miRNA expression profile to obtain a receptivity predictive score using, for example, a computer-based algorithm. Aspects of the disclosure further relate to kits suitable for performing the methods, as well as uses of the kits for diagnostic and therapeutic purposes.
    Type: Application
    Filed: June 26, 2020
    Publication date: January 7, 2021
    Inventors: Shih-Ting KANG, Wei-Ming CHEN
  • Patent number: 10590478
    Abstract: A nucleotide sequence having SEQ ID NO:1, a universal reverse primer having SEQ ID NO:2, and a universal RT primer are provided. In the miRNA detection method, the universal RT primer is used for the cDNA synthesis of a miRNA sample and the universal reverse primer is used for cDNA molecule amplification in qPCR quantitative detection. The universal reverse primer sequence, the nucleotide sequence, and the design rules are used in the method for designing primer, so as to design a primer for qPCR quantitative detection.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: March 17, 2020
    Assignee: Quark Biosciences Taiwan, Inc.
    Inventors: Wei-Ming Chen, Shih-Ting Kang
  • Patent number: 10415085
    Abstract: A nucleotide sequence having SEQ ID NO:1, a universal reverse primer having SEQ ID NO:2, a universal RT primer, a method for designing primer, and a miRNA detection method are provided. In the miRNA detection method, the universal RT primer is used for the cDNA synthesis of a miRNA sample and the universal reverse primer is used for cDNA molecule amplification in qPCR quantitative detection. The universal reverse primer sequence, the nucleotide sequence, and the design rules are used in the method for designing primer, so as to design a primer for qPCR quantitative detection.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: September 17, 2019
    Assignee: Quark Biosciences Taiwan, Inc.
    Inventors: Wei-Ming Chen, Shih-Ting Kang
  • Publication number: 20190106731
    Abstract: A nucleotide sequence having SEQ ID NO:1, a universal reverse primer having SEQ ID NO:2, and a universal RT primer are provided. In the miRNA detection method, the universal RT primer is used for the cDNA synthesis of a miRNA sample and the universal reverse primer is used for cDNA molecule amplification in qPCR quantitative detection. The universal reverse primer sequence, the nucleotide sequence, and the design rules are used in the method for designing primer, so as to design a primer for qPCR quantitative detection.
    Type: Application
    Filed: December 14, 2018
    Publication date: April 11, 2019
    Applicant: Quark Biosciences Taiwan, Inc.
    Inventors: Wei-Ming Chen, Shih-Ting Kang
  • Publication number: 20170022544
    Abstract: A nucleotide sequence having SEQ ID NO:1, a universal reverse primer having SEQ ID NO:2, a universal RT primer, a method for designing primer, and a miRNA detection method are provided. In the miRNA detection method, the universal RT primer is used for the cDNA synthesis of a miRNA sample and the universal reverse primer is used for cDNA molecule amplification in qPCR quantitative detection. The universal reverse primer sequence, the nucleotide sequence, and the design rules are used in the method for designing primer, so as to design a primer for qPCR quantitative detection.
    Type: Application
    Filed: June 1, 2016
    Publication date: January 26, 2017
    Inventors: Wei-Ming Chen, Shih-Ting Kang
  • Publication number: 20150225739
    Abstract: The present invention provides an expression vector comprising an internal ribosome entry site (IRES) element, comprising a sequence of SEQ ID NO: 1, wherein the sequence is an IRES element from a gene icp35 of White spot syndrome virus. The expression vector can be easily operated in insect cells or Crustacean cells and has excellent expression efficiency due to having such an IRES element. A multiple expression gene system is also provided herein, which comprises the expression vector. The system comprising the IRES element can be functioned via transfection, such that the experimental process can be considerably shortened, and thus studying costs will be reduced effectively.
    Type: Application
    Filed: June 26, 2014
    Publication date: August 13, 2015
    Inventors: GUANG-HSIUNG KOU, CHU-FANG LO, SHIH-TING KANG